These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4032596)

  • 1. Cancer serum index and prostatic acid phosphatase for detection of progressive prostatic cancer.
    Robey EL; Schellhammer PF; Wright GL; el-Mahdi AM
    J Urol; 1985 Oct; 134(4):787-90. PubMed ID: 4032596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationship of prealbumin and alpha-1 acid glycoprotein in cancer patient sera.
    Hollinshead AC; Chuang CY; Cooper EH; Catalona WJ
    Cancer; 1977 Dec; 40(6):2993-8. PubMed ID: 589564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical significance of cancer serum index (serum alpha 1 acid glycoprotein to prealbumin ratio) in colorectal cancer: preliminary report].
    Fujimori M; Sekishita Y; Siono T; Kuroshima S
    Nihon Geka Gakkai Zasshi; 1990 Apr; 91(4):533. PubMed ID: 2377168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Host-tumor relationship as a function of the orosomucoid-prealbumin ratio].
    Caldani C; Milano G; Schneider M; Thyss A; Lesbats G; Lalanne CM
    Bull Cancer; 1983; 70(1):1-8. PubMed ID: 6132632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prealbumin, transferrin and alpha-1-acid glycoprotein in patients with gynecological carcinomas.
    Tosner J; Krejsek J; Louda B
    Neoplasma; 1988; 35(4):403-11. PubMed ID: 3141823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute phase reactant proteins in prostatic cancer.
    Ward AM; Cooper EH; Houghton AL
    Br J Urol; 1977 Oct; 49(5):411-8. PubMed ID: 73395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orosomucoid prealbumin ratio in bronchopulmonary cancers].
    Charet JC; Leprêtre A; Watine J; Jounieaux V; Aron C; Charet P
    Ann Biol Clin (Paris); 1995; 53(3):131-4. PubMed ID: 7574097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
    Kaplan LA; Chen IW; Sperling M; Bracken B; Stein EA
    Am J Clin Pathol; 1985 Sep; 84(3):334-9. PubMed ID: 4036863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prostatic acid phosphatase activity and prostate specific antigen when the prostate gland is enlarged.
    Jenkins D; Jones RT; Clarke AM
    Med Lab Sci; 1991 Apr; 48(2):161-3. PubMed ID: 1719330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined serum and bone marrow radioimmunoassays for prostatic acid phosphatase.
    Cooper JF; Foti A; Herschman H
    J Urol; 1979 Oct; 122(4):498-502. PubMed ID: 480493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
    Br Med J; 1978 Sep; 2(6139):719-20. PubMed ID: 698693
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
    Foti AG; Cooper JF; Herschman H; Malvaez RR
    N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison between serum monoclonal prostate specific antigen and acid phosphatase measurements in metastatic prostatic cancer.
    Ahmann FR; Schifman RB
    J Urol; 1987 Mar; 137(3):431-4. PubMed ID: 2434667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in hemodialysis patients.
    Sasagawa I; Nakada T; Hashimoto T; Ishigooka M; Kubota Y; Hirano K; Hirano J; Suzuki Y
    Urol Int; 1992; 48(2):181-3. PubMed ID: 1374977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of prostatic serum acid phosphatase as a tumor marker in prostatic cancer].
    Hamami G
    Hinyokika Kiyo; 1983 Oct; 29(10):1231-45. PubMed ID: 6085711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.